Literature DB >> 6104854

Salazopyrin-induced eosinophilic pneumonia.

S Berliner, A Neeman, Y Shoenfeld, M Eldar, I Rousso, U Kadish, J Pinkhas.   

Abstract

A patient with ulcerative colitis developed eosinophilic pneumonia, sinus tachycardia, skin rashes, headache and insomnia following treatment with Salazopyrin. The pneumonia as well as the other side effects resolved spontaneously following discontinuation of the drug and reappeared when Salazopyrin was readministered.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6104854     DOI： 10.1159/000194205

Source DB:  PubMed          Journal:  Respiration        ISSN： 0025-7931            Impact factor:   3.580


  6 in total

1.  Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies.

Authors:  P Bonniere; B Wallaert; A Cortot; X Marchandise; Y Riou; A B Tonnel; J F Colombel; C Voisin; J C Paris
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

Review 2.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

Review 3.  Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.

Authors:  S B Hanauer; G Stathopoulos
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

4.  Sulfasalazine-induced pulmonary disease.

Authors:  R H Moseley; K W Barwick; K Dobuler; V A DeLuca
Journal:  Dig Dis Sci       Date:  1985-09       Impact factor: 3.199

5.  Sulphasalazine induced hepatitis in juvenile rheumatoid arthritis.

Authors:  D Caspi; D Fuchs; M Yaron
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

6.  Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.

Authors:  R S Amos; T Pullar; D E Bax; D Situnayake; H A Capell; B McConkey
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.